The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the ... Read Full Story »
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ... Read Full Story »
Investors and traders are always looking to find fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh analyst research calls to ... Read Full Story »
These are some of this Thursday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Broadsoft Inc. (NASDAQ: BSFT) downgraded after poor expense guidance at Mizuho, Oppenheimer, ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls this Thursday: ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at UBS but ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Air Products & Chemicals Inc. (NYSE: APD) raised to Buy at ... Read Full Story »
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ... Read Full Story »
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ... Read Full Story »
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold ... Read Full Story »
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August ... Read Full Story »
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the ... Read Full Story »
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the ... Read Full Story »
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Aetna Inc. (NYSE: AET) Reiterated Buy with a target price of ... Read Full Story »